San Diego, CA, United States of America

Jae Moon Lee

This inventor holds 2 USPTO granted patents. Top assignee: Kainos Medicine Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae Moon Lee. Retrieved from https://idiyas.com/inventor/jae-moon-lee-0628n7mw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.2

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jae Moon Lee: Innovator in Organic Compounds

Introduction

Jae Moon Lee is a notable inventor based in San Diego, CA. He has made significant contributions to the field of organic chemistry, particularly in the development of novel compounds. His work is characterized by a focus on practical applications in clinical settings.

Latest Patents

Jae Moon Lee holds a patent for a salt compound of 4-(2-((4-bromophenyl)thio)acetamido)-1-phenethyl-1H-pyrazole-3-carboxylic acid. This patent includes methods for synthesizing the salt compound and formulations for its use in dosage forms intended for clinical applications. He has 1 patent to his name, showcasing his innovative approach to organic compounds.

Career Highlights

Currently, Jae Moon Lee is associated with Kainos Medicine Inc., where he continues to advance his research and development efforts. His work at the company emphasizes the importance of translating scientific discoveries into viable medical solutions.

Collaborations

Throughout his career, Jae Moon Lee has collaborated with talented individuals such as Sungeun Yoo and Sunmi Shin. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Jae Moon Lee's contributions to the field of organic compounds reflect his dedication to innovation and practical application in medicine. His work continues to inspire advancements in clinical formulations and therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…